NextPlat (NXPL) Asset Writedowns and Impairment (2010 - 2026)
NextPlat's (NXPL) quarterly Asset Writedowns and Impairment came in at $16000.0 in Q2 2026, up 151.61% year-over-year from $6359.0 in Q2 2025, and up 166.67% quarter-over-quarter from $6000.0 in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Asset Writedowns and Impairment for 8 consecutive years, with $16000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 151.61% year-over-year to $16000.0 in Q2 2026; TTM through Jun 2026 was $30000.0, a 99.15% decrease from a year earlier, with the FY2025 full-year figure at -$101000.0, up 22.9% from the prior year.
- Asset Writedowns and Impairment was $16000.0 for Q2 2026 at NextPlat, up from $6000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $9.8 million in Q2 2024 and troughed at -$81000.0 in Q4 2024.
- A 5-year average of $1.0 million and a median of $9000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment surged 30975.0% in 2024 and sank 4000.0% in 2025, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $43000.0 in 2022, then decreased by 18.6% to $35000.0 in 2023, then tumbled by 331.43% to -$81000.0 in 2024, then jumped by 98.77% to -$1000.0 in 2025, then jumped by 1700.0% to $16000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $16000.0 (Q2 2026), $6000.0 (Q1 2026), and -$1000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | -78,000.00 |
| Dec 31, 2024 | -81,000.00 |
| Sep 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Jun 30, 2012 | 500,000.00 |
| Jun 30, 2011 | 500,000.00 |
| Sep 30, 2010 | 1.04 Mn |